期刊文献+

Fibulin-1蛋白的真核表达与ELISA检测方法的建立 被引量:2

Establishment of ELISA for measurement of Fibulin-1 employing eukaryotic protein expression
原文传递
导出
摘要 目的建立检测血清中Fibulin-1蛋白浓度的ELISA方法。方法构建Fibulin-1蛋白真核表达载体,以人Fibulin-1基因编码序列为模板,将目的片段定向克隆入载体并转入毕赤酵母菌,进行Fibulin-1蛋白的真核表达。表达产物纯化后,Westernblotting检测证明纯化的重组蛋白的抗原特异性。以该蛋白为定标绘制标准曲线,建立人血清ELISA检测方法并检测其精密度和回收率,最后初步分析人血清中Fibulin-1的含量。结果从真核表达体系获得了纯化的Fibulin-1蛋白,其具有良好的抗原特异性;建立的ELISA方法线性相关系数W=0.98,线性范围为12.5—800ng/mL,检测灵敏度为6.25ng/mL,蛋白回收率在94.33%~109.33%之间,CV均〈10%,具有良好的重复性;检测30例正常人血清样本中Fibulin-1的含量约为(31±8)μg/mL。结论建立的ELISA方法可用于检测血清中的Fibulin-1蛋白含量。 Objective To establish an ELISA method for Fibulin-1 detection in human serum. Methods Firstly, to construct an eukaryotic expression vector of fibulin-1 and express the fusion protein, The human fibulin-1 gene coding sequence was used as templates to amplify the target DNA fragments, which were direct-cloned into a Pichia vector. Secondly, the recombinant fibulin-1 protein was expressed and purified after induction, and western blotting was used to test the antigenieity and specificity of the purified recombinant protein. Then the protein was used as standard to generate an ELISA standard curve, and the accuracy and protein recovery rate were analyzed. Finally, this ELISA method was used to determine the protein concentration of fibulin-1 in human serum. Results The recombinant fibulin-1 protein was successfully expressed from the eukaryotic expression system and purified. The purified protein had good antigenicity and specificity. The linear correlation coefficient of this ELISA method was 0.98, the linear determination range was 12.5-800 ng/mL, the testing sensitivity was 6.25 ng/mL, the protein recovery rate was from 94.33% to 109.33%, the variation coefficient (CV)was less than 10%. The concentration of Fibulin-1 in 30 serum specimens was determined by the this ELISA method and the result was (31±8)μg/mL.
出处 《中华腔镜泌尿外科杂志(电子版)》 2013年第6期56-59,共4页 Chinese Journal of Endourology(Electronic Edition)
基金 国家十二五科技重大专项课题(2012ZX10002017-005 2012ZX10002016-023 2012ZX10002010-001-007) 国家自然科学基金(81000936 81172036) 教育部博士点基金(20100171120107 20100171120084 20120171110082) 广东省自然科学基金(S2012010008792) 中山大学青年教师培育项目(10ykpy05)
关键词 Fibulin—1蛋白 真核表达 酶联免疫吸附测定 Fibulin-1 Eukaryotic Expression ELISA
  • 相关文献

参考文献10

  • 1Gallagher WM, Currid CA, Whelan LC. Fibulins and cancer: friend or foe? Trends Mol Med, 2005, 11(7): 336-340.
  • 2Wlazlinski A, Engers R, Hoffmann MJ, et al. Downregulation of several fibulin genes in prostate cancer. Prostate, 2007, 67(16): 1770-1780.
  • 3傅斌生,刘炜,张剑文,台艳,易慧敏,张琪,杨扬,陈规划.肝细胞肝癌患者血清和肝癌组织中fibulin-1蛋白的表达及其临床意义[J].中华肝脏外科手术学电子杂志,2013,2(3):35-38. 被引量:9
  • 4Argraves WS, Tran H, Burgess WH, et al. Fibulin is an extracellular matrix and plasma glycoprotein with repeateddomain structure. J Cell Biol, 1990, lll(6Pt2): 3155-3164.
  • 5Twal WO, Czirok A, Hegedus B, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci, 2001, l l4(pt 24): 4587-4598.
  • 6Tran H, Tanaka A, Litvinovich SV, et al. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J Biol Chem, 1995, 270(3): 19458-19464.
  • 7Clinton GM, Rougeot C, Derancourt J, eta|. Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer ceils. Proc Natl Acad Sci USA, 1996, 93(1): 316-320.
  • 8Qing J, Maher VM, Tran H, et al. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-lD in human fibrosarcoma-derived cell linea Oncogene, 1997, 15(18): 2159-2168.
  • 9Hayashido Y, Lucas A, Rougeot C, et al. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer ceils induced by fibronectin. Int J Cancer, 1998, 75(4): 654-658.
  • 10Lamote K, Baas P, van Meerbeeck JP. Fibulin-3 as a biomarker for pleural mesothelioma. N Engl J Med, 2013, 368(2): 189-190.

二级参考文献18

  • 1Cheng YY, Jin H, Liu X, et al. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer, 2008,99(12): 2083-2087.
  • 2Pupa SM, Argraves WS, Forti S, et al. Immunological and pathobiological roles of fibulin-l in breast cancer. Oncogene, 2004, 23(12): 2153-2160.
  • 3Bardin A, Moll F, Margueron R, et al. Transcriptional and posttranscriptional regulation of fibulin-I by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology, 2005, 14 760-768.
  • 4Wlazlinski A, Engers R, Hoffmann MJ, et al. Downregulation of several fibulin genes in prostate cancer. Prostate, 2007, 67 (16): 1770-1780.
  • 5Timpl R, Sasaki T, Kostka G, et al. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Bioi, 2003, 4(6): 479-489.
  • 6Weigell-Weber M, Sarra GM, Kotzot D, et al. Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-I) in a previously undescribed vitreoretinal dystrophy. Arch Ophthalmol, 2003, 121 (8): 1184-1188.
  • 7Kubota Y, Kuroki R, Nishiwaki K. A fibulin-I homolog interacts with an ADAM protease that controls cell migration in C. elegans. Curr Bioi, 2004, 14(22): 2011-2018.
  • 8Cangemi C, Skov V, Poulsen MK, et al. Fibulin-I is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chern, 2011, 57(11): 1556-1565.
  • 9Courtney HS, Li Y, Twal WO, et al. Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1. J Bioi Chern, 2009, 284(19): 12966-12971.
  • 10Pi scaglia F, Dudas J, Knittel T, et al. Expression of ECM proteins fibulin-I and -2 in acute and chronic liver disease and in cultured rat liver cells. Cell Tissue Res, 2009, 337(3): 449-462.

共引文献8

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部